Atrial Fibrillation | UMCG | Publications Isabelle C. Van Gelder
16403
page-template-default,page,page-id-16403,ajax_fade,page_not_loaded,,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-4.12,vc_responsive

Publications Isabelle C. Van Gelder

Key publications Van Gelder

H Factor: 60.

Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent AF – results of the RACE 3 trial. Rienstra M, Hobbelt AH, Alings MA, Tijssen JGP, Smit MD, Brügemann J, Geelhoed B, Tieleman RG, Hillege HL, Tukkie R, Van Veldhuisen DJ, Crijns HJGM, Van Gelder IC, for the RACE 3 Investigators. Eur Heart J 2017: accepted.

 

Rate control in atrial fibrillation. Van Gelder IC, Rienstra M, Crijns HJ, Olshansky B. Lancet. 2016;388(10046):818-28.

 

Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation. Spronk HM, De Jong AM, Verheule S, De Boer HC, Maass AH, Lau DH, Rienstra M, van Hunnik A, Kuiper M, Lumeij S, Zeemering S, Linz D, Kamphuisen PW, Ten Cate H, Crijns HJ, Van Gelder IC, van Zonneveld AJ, Schotten U. Eur Heart J. 2016. pii: ehw119. [Epub ahead of print]

 

Lone atrial fibrillation: does it exist ? Wyse DG, Van Gelder IC, Ellinor PT, Go AS, Kalman JM, Narayan SM, Nattel S, Schotten U, Rienstra M. J Am Coll Cardiol 2014;63:1715-23.

 

Temporal relationship between subclinical atrial fibrillation and embolic events. Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, Lau CP, Van Gelder IC, Hohnloser SH, Carlson M, Fain E, Nakamya J, Mairesse GH, Halytska M, Deng WQ, Israel CW, Healey JS; ASSERT Investigators. Circulation 2014;129:2094-9.

 

Subclinical atrial fibrillation and the risk of stroke. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH. New Engl J Med 2012;366:120-9.

 

Lenient versus strict rate control in patients with atrial fibrillation. Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, Van Veldhuisen DJ, Van den Berg MP; RACE II Investigators. New Engl J Med 2010;362:1363-73.

 

Continuous versus episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: A randomized trial. Ahmed S, Rienstra M, Crijns HJGM, Links TP, Wiesfeld ACP, Hillege HL, Bosker HA, Lok DJA, Van Veldhuisen DJ, Van Gelder IC. JAMA 2008;300:1784-92.

 

Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation. Hemels ME, Van Noord T, Crijns HJ, Van Veldhuisen DJ, Veeger NJ, Bosker HA, Wiesfeld AC, Van den Berg MP, Ranchor AV, Van Gelder IC. J Am Coll Cardiol 2006;48:1001-9.

 

Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study. Rienstra M, Van Gelder IC, Hagens VE, Veeger NJ, Van Veldhuisen DJ, Crijns HJGM. Eur Heart J 2006;27:357-64.

 

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJM, Tijssen JGP, Crijns HJGM. N Engl J Med 2002;347:1834-40.